Vera Grinkevich

Company: Artios Pharma

Job title: Associate Director

Seminars:

Harnessing Pol Theta Inhibition as a Cancer Specific DDR Target to Overcome Resistance in PARPi-Resistant Cancers 11:00 am

Discussing the mechanistic role of pol theta in DNA double-strand break (DSB) repair and DNA damage tolerance through translesion synthesis, with potential to address resistance in PARPi-resistant cancers and enhance the efficacy of DNA-damaging agents like chemotherapy and ionizing radiation Examining how pol theta inhibitors offer the potential to selectively target tumor cells while sparing…Read more

day: Day One